Investment
Features
FeesSafety
Academy
More
Pluang+

SUBSCRIBE and FactSet partner to streamline private fund investments with integrated digital tools.

Market News
06 Oct 2026
PRNewsWire
View Source
Bullish
SUBSCRIBE and FactSet partner to streamline private fund investments with integrated digital tools.

SUBSCRIBE, a fintech company specializing in alternative investments, has partnered with FactSet to integrate its private markets workflow into FactSet's platform. This collaboration enables institutional investors and wealth managers to onboard investors, subscribe to funds digitally, and centralize investment reporting within a single platform. The integration enhances management and analysis of both private and public investments, supporting over $6 trillion in private market assets and expanding SUBSCRIBE's reach to FactSet's extensive client base. This partnership aims to modernize private market investment processes and improve portfolio visibility as alternative investments grow.

SUBSCRIBE's partnership with FactSet to enhance private markets solutions is presented here with Financials sector data from Pluang as of Oct 06, 2026 18:43 WIB. For readers following Financials, here is Pluang's market snapshot: out of 85 priced US Financials stocks, 70 rose and 10 fell today. Notable movers include AVAT at USD 1.97 with a 1-day change of +5.35%, ING at USD 35.29 with a 1-day change of +1.50%, and RIOT at USD 19.60 with a 1-day change of +1.45%.

More News

Costco shares drop 10% in 6 months while S&P 500 rises 17%, raising value questions below $900.

Costco shares drop 10% in 6 months while S&P 500 rises 17%, raising value questions below $900.

Over the past six months, Costco's stock has fallen by 10%, contrasting with the S&P 500's 17% gain. This decline has sparked debate on whether Costco's shares, now trading under $900, represent a buying opportunity. Investors are weighing if the pri...

Analyst Insights
Neutral
3 hours ago
IceCure Medical adds Legacy Health to U.S. study on cryoablation for low-risk breast cancer

IceCure Medical adds Legacy Health to U.S. study on cryoablation for low-risk breast cancer

IceCure Medical has expanded its U.S. clinical network for the ChoICE Study by adding Legacy Health in Oregon as a new site. The study evaluates the safety and effectiveness of ProSense® cryoablation, a minimally invasive treatment for low-risk breas...

Market News
Bullish
4 hours ago
Palantir's stock jumps 60% in Q3, its best quarter in over a year, but high valuation demands flawless growth.

Palantir's stock jumps 60% in Q3, its best quarter in over a year, but high valuation demands flawless growth.

Palantir Technologies saw its stock rise 60.3% in the third quarter, marking its strongest quarterly gain since mid-2025, driven by a 93% revenue increase to $1.935 billion and a 149% jump in U.S. commercial revenue. Despite this surge, Palantir is o...

Company Fundamentals
Bullish
4 hours ago
Nike shares hit worst year but long-term investors see buying opportunity amid turnaround hopes

Nike shares hit worst year but long-term investors see buying opportunity amid turnaround hopes

Nike shares are performing poorly this year, reflecting investor skepticism due to the company's struggling operating results. Despite the negative sentiment, analyst Justin Purohit believes that long-term investors could benefit from holding onto or...

Analyst Insights
Bullish
4 hours ago
Dogecoin offers no staking yield; any DOGE yield comes from lending with risks and tax implications.

Dogecoin offers no staking yield; any DOGE yield comes from lending with risks and tax implications.

Dogecoin's protocol does not support staking, so any yield offered on DOGE holdings comes from third-party lending services, not from the blockchain itself. Dogecoin operates on proof of work, issuing about 3.2% new supply annually, which dilutes hol...

Protocol Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App